Input feed: Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items
RSS
ATOM
JSON
Sort by:
Date tagged
Date published
-
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
https://api.zotero.org/groups/2494380/items/TLAQPAWG?format=atom
Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 11/27/2020
-
Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial
https://api.zotero.org/groups/2494380/items/N5VYNNUJ?format=atom
Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 11/25/2020